Abstract
Children undergoing systemic chemotherapy often suffer from severe immunosuppression usually associated to severe neutropenia (neutrophils < 0.5 x 109/l). Clinical courses during those periods range from asymptomatic to septic general conditions. Development of septic symptoms can be very fast and life-threatening. Swift detection of risk factors in those patients is therefore needed. So far no early, rapid and reliable marker or tool exists. Ion-Mobility-Spectrometry coupled with a Multi-Capillary-Column (IMS-MCC) can analyze more than 600 volatile components from exhaled air within a few minutes and hence is a potential, rapid detection-tool. As a proof of concept we measured the exhaled breath of 11 patients with neutropenia and 10 healthy controls ranging from 3 to 18 years of age at the time of measurement. Ten milliliters breath samples were taken at the outpatient clinic and analyzed with an onsite IMS-MCC (BreathDiscovery, B&S Analytik, Dortmund, Germany). Dead-space-volume was adapted to two groups (small 250 ml, large 500 ml). Interestingly 59 differing peaks were measured. Eleven were significantly different (p ≤ 0.05), three of which highly significant (p ≤ 0.01) in Mann-Whitney-Rank-Sum-testing. The corresponding analytes used in the decision tree are 2-Propanol, D-Limonene and Acetone. The analytes with the lowest rank sum identified are 2-Hexanone, Iso-Propylamine and 1-Butanol. Eventually we were able to show a three-step-decision-tree, which discerns the 21 samples except one from each group. Sensitivity was 90 % and specificity was 91 %. Naturally these findings need further confirmation within a bigger population. Our pilot-study proves that Ion-Mobility-Spectrometry coupled with a Multi-Capillary-Column is a feasible rapid diagnostic tool in the setting of a pediatric oncology out-patient clinic for patients 3 years and older. Our first results furthermore encourage additional analysis as to whether patients at risk for septic events during immunosuppression can be diagnosed in advance by rapidly assessing risk factors such as Neutropenia in exhaled breath.
References
Simon A, Ammann RA, Bode U et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70
Ammann RA, Tissing WJE, Phillips B (2012) Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis 25:258–265
Agyeman P, Aebi C, Hirt A et al (2011) Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J 30:e114–e119
Baumbach JI (2009) Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res 3:034001
Jünger M, Vautz W, Kuhns M et al (2012) Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria. Appl Microbiol Biotechnol 93:2603–2614
Maddula S, Blank LM, Schmid A, Baumbach JI (2009) Detection of volatile metabolites of escherichia coli by multi capillary column coupled ion mobility spectrometry. Anal Bioanal Chem 394:791–800
Maddula S, Rabis T, Sommerwerck U et al (2011) Correlation analysis on data sets to detect infectious agents in the airways by ion mobility spectrometry of exhaled breath. Int J Ion Mobil Spectrom 14:197–206
Rabis T, Sommerwerck U, Anhenn O et al (2011) Detection of infectious agents in the airways by ion mobility spectrometry of exhaled breath. Int J Ion Mobil Spectrom 14:187–195
Fazekas T, Eickhoff P, Lawitschka A, Knotek B, Potschger U, Peters C (2012) Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation. Eur J Pediatr 171:1095–1101
Schneider T et al (2013) An integrative clinical database and diagnostics platform for biomarker identification and analysis in ion mobility spectra of human exhaled air. J Integr Bioinforma 10(2):218
Hauschild A-C et al (2013) Peak detection method evaluation for ion mobility spectrometry by using machine learning approaches. Metabolites 3:277–293
Hauschild A-C et al (2012) Computational methods for metabolomic data analysis of ion mobility spectrometry data—reviewing the state of the art. Metabolites 2:733–755
Hauschild A-C, Baumbach JI, Baumbach JI (2012) Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification. Genet Mol Res 11(3):2733–2744
Westhoff M et al (2011) Statistical and bioinformatical methods to differentiate chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control by breath analysis using ion mobility spectrometr. Int J Ion Mobil Spectrom 11(4):139–149
Rabis T et al (2011) Detection of infectious agents in the airways by ion mobility spectrometry of exhaled breath. Int J Ion Mobil Spectrom 11(4):187–195
Vogtland D, Baumbach JI (2009) Breit-Wigner-function and IMS-signals. Int J Ion Mobil Spectrom 12:109–114
Bödeker B, Baumbach JI (2009) Analytical description of IMS-signals. Int J Ion Mobil Spectrom 12:103–108
Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach J (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64:744–748
Westhoff M, Litterst P, Maddula S et al (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 13:131–139
Westhoff M, Litterst P, Maddula S, Bödeker B, Baumbach JI (2011) Statistical and bioinformatical methods to differentiate chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 14:139–149
Acknowledgments
We thank Prof. N. Graf and the Elterninitiative krebskranker Kinder im Saarland e.V. for their financial support of this study. The data analysis part of the work of this paper (JIBB) has been supported by Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) SFB 876 “Providing Information by Resource-Constrained Analysis”, project TB1 “Resource-Constrained Analysis of Spectrometry Data”.
Conflict of interest
JIBB is a shareholder of, BB and SM are employed at B&S Analytik GmbH, the manufacturer of BreathDiscovery.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furtwängler, R., Hauschild, AC., Hübel, J. et al. Signals of neutropenia in human breath?. Int. J. Ion Mobil. Spec. 17, 19–23 (2014). https://doi.org/10.1007/s12127-014-0145-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12127-014-0145-9